title: [Isolation of Shewanella algae from pleural exudate of patient with pneumonia].
abstract: OBJECTIVE
  Clinical-microbiological description of the first case in Russia of isolation of S. algae bacteria from clinical material.
  
  
  METHODS
  Patient P., 23 years of age, diagnosis: right-sided distal pneumonia, severe course; parapneumonic empyema of pleura. Bacteria isolation, cultural and biochemical tests differentiating S. algae and Shewanella putrefaciens were performed according to Holt H.M. et al., 2005. Identification of bacteria, tests of sensitivity to antibiotics were carried out by automatic system Vitek 2 (bioMerieux) and additionally by disc-diffusion method.
  
  
  RESULTS
  S. algae in association with Serratia marcescens were isolated from pleural exudate of the patient with pneumonia. S. algae bacteria had typical taxonomical features and pathogenicity factors (lipase, gelatinase, beta-hemolysin); were resistant to benzylpenicillin, amoxicillin, cefazolin and sensitive to other beta-lactam antibiotics, aminoglycosides, fluoroquinolones, macrolides, tetracycline.
  
  
  CONCLUSIONS
  S. algae bacteria isolated from pleural exudate of the patient with pneumonia are etiologically significant in parapneumonic empyema of pleura.
authors.forename: E P
authors.initials: EP
authors.lastname: Sivolodskiĭ
authors.forename: B N
authors.initials: BN
authors.lastname: Kotiv
authors.forename: E N
authors.initials: EN
authors.lastname: Kolobova
authors.forename: G V
authors.initials: GV
authors.lastname: Gorelova
authors.forename: S P
authors.initials: SP
authors.lastname: Bogoslovskaia
authors.forename: O V
authors.initials: OV
authors.lastname: Barinov
authors.forename: F V
authors.initials: FV
authors.lastname: Ivanov
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D015373:Bacterial Typing Techniques; D024901:Drug Resistance, Multiple, Bacterial; D004653:Empyema / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D016905:Gram-Negative Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D010994:Pleura / Q000187:drug effects / Q000382:microbiology; D010996:Pleural Effusion / Q000382:microbiology; D018410:Pneumonia, Bacterial / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D012706:Serratia marcescens / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D020592:Shewanella / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents